Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heron Therapeutics (NQ: HRTX )

2.665 -0.045 (-1.66%)
Streaming Delayed Price Updated: 10:00 AM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 176,885
Open 2.710
Bid (Size) 2.660 (29)
Ask (Size) 2.670 (23)
Prev. Close 2.710
Today's Range 2.665 - 2.740
52wk Range 0.5000 - 3.220
Shares Outstanding 140,759,276
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?
Heron Therapeutics' Q4 2023 results: Beat EPS consensus at $(0.07), $34.23 million sales, up 14% Y/Y. Strong momentum in acute and oncology care franchises. Fiscal year 2024 guidance: $138 million-$158... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga

Performance

YTD
+41.01%
+41.01%
1 Month
-9.66%
-9.66%
3 Month
+27.51%
+27.51%
6 Month
+318.17%
+318.17%
1 Year
-1.30%
-1.30%

More News

Read More
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Heron Therapeutics: Q4 Earnings Insights
Via Benzinga
Preview: Heron Therapeutics's Earnings
Via Benzinga
Heron Therapeutics's Earnings Outlook
Via Benzinga
Earnings Scheduled For March 12, 2024
Via Benzinga
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod
Via Benzinga
Exposures Product Safety
Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
The 3 Most Undervalued Biotech Stocks to Buy in January
Via InvestorPlace
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
Via InvestorPlace
Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Rises Over 100 Points; Target Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
US Stocks Gain; Producer Prices Fall In October
Via Benzinga
Topics Stocks
Exposures US Equities
Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.